Prostasomes are organelles secreted by prostatic epithelial cells, and are believed to have a role in fertility and prostatic disease. They are known to influence sperm motility and the acrosome reaction, and are thought to have a role in cell transformation, immunosuppression, proliferation, facilitation of local invasion, and angiogenesis. Previously, we have demonstrated the inhibitory effect of prostasomes derived from human semen on angiogenesis using HUVEC cells grown on matrigel. In this study, we use the rat aortic ring assay system, arguably a closer reflection of the in vivo situation. Quantification was by a spectrophotometric method, and underlying mechanisms assessed. Prostasomes demonstrated a clear inhibition of angiogenesis, and this effect persisted after heat treatment of prostasomes to denature protein. This fits with other known effects of prostasomes known to be due to the membrane lipid component, which is unusually high in sphingomyelin and cholesterol.
Introduction
Prostasomes are organelles that are secreted by prostatic epithelial cells, which have been shown to have a biologically important role in fertility, affecting sperm motility, 1 the acrosome reaction, 2 and immunomodulation. 3 Prostasomes are also known to have an antioxidant effect, via stabilization of polymorphonuclear neutrophil cell membranes. 4 Proteomic analysis of prostasomes has shown them to contain more than 130 proteins, including complement inhibitors, tissue factor (CD142), and dipeptidyl peptidase IV, which has been shown to be involved in the modulation of growth factor and cytokine activity. [5] [6] [7] The membranes of prostasomes are unusual in that they are particularly rich in cholesterol and sphingomyelin. 8 Prostasome-like particles are also known to be released by prostate cancer cells, both in vitro and in vivo. 9, 10 The wide range of bioactive proteins and known biological effects associated with prostasomes has led to the belief that they may influence prostatic disease. Ronquist and Nilsson suggest that prostasomes may have a wide range of promalignant properties, affecting cell transformation, immunosuppression, proliferation, facilitation of local invasion, and promotion of angiogenesis. 11 Despite this there has been relatively little experimental evidence to either confirm or refute these views, beyond a study demonstrating that semenderived prostasomes exert a growth-inhibitory effect on prostate cancer cells grown in culture. 12 We have previously examined the influence of prostasomes on angiogenesis, demonstrating interaction of prostasomes with endothelial cells and the inhibition of tubule formation by human umbilical vein endothelial cells (HUVEC) grown on matrigel. 13 In this study, we have now studied the effect of prostasomes on angiogenesis in the rat aortic ring assay, which is a closer reflection of the in vivo situation, and tried to examine the mechanism(s) underlying any effect. Quantification of results was by a spectrophotometric method described by Wang et al., 14 which depends upon viable cells to reduce MTS to a soluble formazan product measurable by spectrophotometry, in a similar manner to that of the better known MTT assays. This method has the advantage of being relatively simple, not requiring complicated image analysis software, and is free from the risk of nonrepresentative images being obtained for analysis.
Materials and methods

Prostasomes
Prostasomes were isolated from pooled post vasectomy human semen, according to the protocol described by Ronquist and Brody. 15 The semen was initially centrifuged at 10 000 g for 15 min to separate cells from the seminal plasma. The supernatant was then subjected to ultracentrifugation, at 100 000 g for 2 h at 41C. The resulting pellet was resuspended in Ca 2 þ /Mg 2 þ -free Dulbecco's phosphate-buffered saline (Sigma, Poole, UK). The suspension was further purified by Sephadex 200 (Sigma) gel chromatography in order to purify prostasomes from amorphous substance. The Sephadex column was equilibrated and eluted with PBS, at a flow rate of 0.5 ml/min. Fractions of 2.5 ml were collected. The presence of prostasomes in fractions was demonstrated by assay for amino-peptidase activity, 16 and spectrophotometry at 280 nm. 17 Prostasome containing fractions were pooled, and the protein concentration measured. 18 The suspension was subdivided into 1 ml aliquots and frozen at À201C.
To denature prostasomal protein, prostasome preparations were heated at 1001C for 10 min, as previously described. 19 This degree of heat-treatment is known to be highly effective in denaturing protein. 20 This process degrades the structure of vesicles as well as denaturing protein, but the ability to influence biological systems seemed to be preserved.
Aortic ring
A 50/50 mix of Medium 200 (Cascade Biologics, Mansfield, UK), supplemented with amphotericin B (Sigma) at 0.4 mg/ml. and L-glutamine-PenicillinStreptomycin (Sigma) (giving concentrations of 2 mM L-glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin), and growth-factor depleted Matrigel (BD Biosciences, Oxford, UK) was prepared, and 100 ml pipetted into each of the central 24 wells of a 48-well plate (Nunc, Fisher Scientific, Loughborough, UK). The plate was placed in an incubator maintained at 371C and 5% carbon dioxide, to allow the gel to set. Thoracic aortas were harvested from 8-week old male Wistar rats: the aortas were briefly immersed in 70% ethanol, before being rinsed in the supplemented Medium 200. The vessels were stripped of fat and connective tissue, before being divided into equal 1 mm segments. A single segment was placed in the centre of each well, and a further 150 ml of the medium/matrigel mix was pipetted over the ring. After a further 30 min in the incubator to allow the gel to set, before 125 ml of supplemented medium 200 was added to each well. The empty peripheral wells were filled with Dulbecco's PBS to prevent desiccation.
On day 2, either test agent or control (Dulbecco's PBS) to a volume of 100 ml was added to each well. On day 6, 300 ml of solution containing 100 mg of 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2H-tertrazolium (MTS; Promega, Southampton, UK) and 1 mg of phenazine methosulfate (PMS; Sigma) was added to each well. After 24 h, 150 ml of fluid was aspirated from each well and absorbance of light at 490 nm was measured using a PowerWave 340 spectrophotometer (Bio-Tek Instruments, Winooski, Vermont, USA).
Results
Both untreated and boiled prostasomes at doses of 50 and 100 ml caused a statistically significant reduction (Po0.005) in angiogenesis activity, as measured by a spectrophotometric method (Figure 1) . The reductions in absorbance caused by 50 ml of prostasomes, 100 ml of prostasomes, and the boiled prostasome preparation relative to the control were 12.5, 13.4 and 23.1%, respectively. There was no significant difference between prostasome treatment doses.
The visualization of the aortic rings themselves (Figure 2 ) suggests that this method of quantification underestimates the degree of inhibition, probably due to the effect of viable cells within the aortic ring itself.
Discussion
The principle finding of this study was the unambiguous in vitro inhibition of angiogenesis by seminal prostasomes, confirming our earlier work with HUVECs, 13 at levels of prostasomes calculated to be comparable with that found in whole semen. 21 Previously, we showed that the inhibition does not appear to be simply due to inhibition of cell proliferation, 13 and here we show the effect to be preserved after heat treatment of the prostasomes suggesting, that the effect is not protein dependent. Our earlier experiments with fluorescent labelled prostasomes show that prostasomal membranes interact with those of endothelial cells, 13 in a similar manner to that previously described by others with spermatozoa and leucocytes. Interaction with spermatozoa results in the transfer of enzyme activity 22, 23 and altered membrane fluidity. 24 The lipid component of prostasomes has been demonstrated to be effective in their immunosuppressive and antioxidant properties. 25 
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Extracellular membrane vesicles from tumour cells (EMVTCs) are particles shed from the surface of tumour cells. Despite the differences in method of release, they appear to be similar to prostasomes: they are rich in surface antigens and proteases, and have membranes containing increased amounts of cholesterol and sphingomyelin. 19 Work with EMVTCs from the HT1080 fibrosarcoma cell line has shown promotion of angiogenesis (using an endothelial cell/matrix and chick chorioallantoic membrane model) by a mechanism in which sphingomyelin is the major active component. 19 Preparations of EMVTCs, which were heat treated to degrade the protein content, were also shown to enhance angiogenic activity, suggesting that protein exchange or activity is not a significant contributor to any effect. The group also studied the lipid component of the EMVTCs, and demonstrated that sphingomyelin promoted angiogenic activity. Sphingomyelin purified from EMVTCs had a degree of activity comparable to that of unrefined EMVTCs, leading the authors to conclude that sphingomyelin is the major active component in angiogenesis promoted by EMVTCs. 19 Sphingomyelin is a phospholipid, which, together with cholesterol, is known to be rigidifying component of plasma membranes. The group also describe the preparation of EMVTCs from the conditioned medium of the prostate cancer cell line DU145. It is claimed that these EMVTCs promoted angiogenic activity in a similar manner to those derived from HT1080 human fibrosarcoma, although interestingly no data derived from DU145 EMVTCs were given. 19 Previous work from our laboratory, using exosomes derived from a variety of prostate cancer cell lines cultured in monolayer applied to HUVEC cells grown on matrigel, has also suggested that angiogenesis is promoted by exosomes derived from malignant cells. 27 This work has only been presented as an abstract, with no formal quantification of either the concentration of exosomes applied or extent of angiogenesis. It also suggests that CD142, tissue factor, may be the factor responsible for promoting angiogenesis, although the work described above and the results presented in this paper both suggest that proteins are probably not a significant contributor. Despite these limitations, it is interesting that exosomes derived from malignant cells are again believed to promote angiogenesis.
The contrast between our findings, which show inhibition of angiogenesis in the two in vitro models used, and those of the two studies above is interesting. However, it is known that there are similar but nonidentical banding patterns on electrophoresis of prostasomal protein derived from benign and malignant sources, 10 emphasizing that it cannot be assumed that prostasomes derived from semen and cell lines in culture will have identical properties. The lipid and membrane properties of exosomes derived from normal murine thymocytes and leukaemic GRSL cells have been compared, 28 with markedly greater cholesterol and sphingomyelin content and more rigid membranes in the exosomes derived from the malignant cells, and although no comparable work has been carried out with prostate cells, it would not be unreasonable to think that there might be a comparable phenomenon. Such differences would help to explain that the effects on angiogenesis do not appear to be protein dependent.
All of the studies performed, as well as those discussed here suffer from the limitations of artificiality. Although the aortic ring assay benefits from the presence of more cell types than simple endothelial cells, and the chick chorioallantoic membrane system is a living system, neither fully represents the physiology and microanatomy of the prostate. Prostasomes are released from the apical surface of the prostatic epithelial cells, into the prostatic ducts. Whether prostasomes are able to exert any effects within the substance of the prostate from this location is unknown, although it may be that disruption of the local tissue architecture, such as might occur in tumour development, would allow prostasomes greater tissue penetration to influence pathogenesis or disease progression.
In conclusion, these experiments demonstrated inhibition of angiogenesis by prostasomes, in a complex ex vivo model -taking forward our earlier finding using a simple HUVEC system. Our current findings suggest that these effects may be independent of prostasomal protein, but rather depend upon prostasomal lipid, similarly to other known actions of prostasomes. Further work on the composition of exosomes from malignant Seminal prostasomes inhibit the angiogenesis activity GH Delves et al and nonmalignant sources might help to clarify the component of a prostasome responsible for influencing angiogenesis, and why there appears to be a difference in effect between these two types of exosome.
